First-Line Treatment of HER2-Positive Metastatic Breast Cancer
2 Mga view
• 07/03/23
0
0
I-embed
administrator
Mga subscriber
Panelists discuss the combination of trastuzumab, pertuzumab, and docetaxel as frontline treatment for patients with HER2-positive metastatic breast cancer.
To view more from this discussion, visit http://www.onclive.com/peer-exchange/mbc-community
Magpakita ng higit pa
Mga Komento sa Facebook
SORT BY-
Mga Nangungunang Komento
-
Pinakabagong komento